LOS ANGELES, Aug. 18, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Spectrum Pharmaceuticals, Inc. ("Spectrum " or "the Company") (NASDAQ: SPPI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5...
Related Questions
How might the securities class action lawsuit affect SPPI's short‑term price volatility and trading volume?
What is the estimated financial exposure (potential settlement or judgment) for Spectrum Pharmaceuticals and how could it impact earnings guidance?
How does this legal exposure compare to recent securities‑law suits in the biotech sector, and what precedent might shape the case’s outcome?